Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
European Journal of Haematology|August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Leukemia|February 1, 2017
Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)A Chanan-Khan, M Egyed, T Robak, et al.
European Journal of Haematology|January 26, 1999
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in PolandT Robak, M Błasińska-Morawiec, J Błoński, et al.
European Journal of Haematology|October 24, 1997
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseasesT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Annals of Hematology|December 3, 2003
Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experienceT Robak, A Szmigielska-Kapłon, A Wrzesień-Kuś, et al.
Annals of Hematology|April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia GroupA Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemiaT Robak, M Błasińska-Morawiec, J Z Błoński, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Annals of Hematology|March 9, 2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)A Wrzesień-Kuś, T Robak, A Pluta, et al.
Leukemia|October 6, 2001
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemiaT Robak, J Z Błoński, M Kasznicki, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
European Journal of Haematology|August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Leukemia|February 1, 2017
Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)A Chanan-Khan, M Egyed, T Robak, et al.
European Journal of Haematology|January 26, 1999
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in PolandT Robak, M Błasińska-Morawiec, J Błoński, et al.
European Journal of Haematology|October 24, 1997
2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseasesT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Annals of Hematology|December 3, 2003
Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experienceT Robak, A Szmigielska-Kapłon, A Wrzesień-Kuś, et al.
Annals of Hematology|April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia GroupA Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemiaT Robak, M Błasińska-Morawiec, J Z Błoński, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Annals of Hematology|March 9, 2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)A Wrzesień-Kuś, T Robak, A Pluta, et al.
Leukemia|October 6, 2001
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemiaT Robak, J Z Błoński, M Kasznicki, et al.
Pageof 30